Literature DB >> 19293956

The quest for a meaningful evidence base in psychiatry.

Robin Emsley1, Sue Hawkridge.   

Abstract

Year:  2009        PMID： 19293956      PMCID： PMC2652896          DOI： 10.1002/j.2051-5545.2009.tb00205.x

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  9 in total

1.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

2.  Financial conflicts of interest in psychiatry.

Authors:  Giovanni A Fava
Journal:  World Psychiatry       Date:  2007-02       Impact factor: 49.548

3.  Impugning the integrity of medical science: the adverse effects of industry influence.

Authors:  Catherine D DeAngelis; Phil B Fontanarosa
Journal:  JAMA       Date:  2008-04-16       Impact factor: 56.272

4.  Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

Authors:  Peter B Jones; Thomas R E Barnes; Linda Davies; Graham Dunn; Helen Lloyd; Karen P Hayhurst; Robin M Murray; Alison Markwick; Shôn W Lewis
Journal:  Arch Gen Psychiatry       Date:  2006-10

5.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

Review 6.  Randomized controlled trials in schizophrenia: a critical perspective on the literature.

Authors:  S Gilbody; K Wahlbeck; C Adams
Journal:  Acta Psychiatr Scand       Date:  2002-04       Impact factor: 6.392

7.  Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.

Authors:  René S Kahn; W Wolfgang Fleischhacker; Han Boter; Michael Davidson; Yvonne Vergouwe; Ireneus P M Keet; Mihai D Gheorghe; Janusz K Rybakowski; Silvana Galderisi; Jan Libiger; Martina Hummer; Sonia Dollfus; Juan J López-Ibor; Luchezar G Hranov; Wolfgang Gaebel; Joseph Peuskens; Nils Lindefors; Anita Riecher-Rössler; Diederick E Grobbee
Journal:  Lancet       Date:  2008-03-29       Impact factor: 79.321

8.  Suicidality in pediatric patients treated with antidepressant drugs.

Authors:  Tarek A Hammad; Thomas Laughren; Judith Racoosin
Journal:  Arch Gen Psychiatry       Date:  2006-03

9.  Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.

Authors:  Joseph P McEvoy; Jeffrey A Lieberman; Diana O Perkins; Robert M Hamer; Hongbin Gu; Arthur Lazarus; Dennis Sweitzer; Christina Olexy; Peter Weiden; Stephen D Strakowski
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112
  9 in total
  1 in total

1.  Measuring Treatment Response in Pediatric Trichotillomania: A Meta-Analysis of Clinical Trials.

Authors:  Luis C Farhat; Emily Olfson; Jessica L S Levine; Fenghua Li; Martin E Franklin; Han-Joo Lee; Adam B Lewin; Joseph F McGuire; Omar Rahman; Eric A Storch; David F Tolin; Hana F Zickgraf; Michael H Bloch
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-12-02       Impact factor: 2.576
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.